These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11224704)

  • 1. Bone marrow transplantation in sickle cell anemia.
    Hoppe CC; Walters MC
    Curr Opin Oncol; 2001 Mar; 13(2):85-90. PubMed ID: 11224704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for sickle cell disease: where do we go from here?
    Walters MC
    J Pediatr Hematol Oncol; 1999; 21(6):467-74. PubMed ID: 10598656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.
    Bolaños-Meade J; Brodsky RA
    Curr Opin Oncol; 2009 Mar; 21(2):158-61. PubMed ID: 19532018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Aslam HM; Yousuf S; Kassim A; Iqbal SM; Hashmi SK
    Bone Marrow Transplant; 2018 Nov; 53(11):1390-1400. PubMed ID: 29728697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
    Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
    Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Nickel RS; Kamani NR
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):219-227. PubMed ID: 28870775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of hematopoietic cell transplantation for sickle cell disease.
    Walters MC
    Curr Opin Hematol; 2015 May; 22(3):227-33. PubMed ID: 25767957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.
    Bhatia M; Kolva E; Cimini L; Jin Z; Satwani P; Savone M; George D; Garvin J; Paz ML; Briamonte C; Cruz-Arrieta E; Sands S
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):666-72. PubMed ID: 25559691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease.
    Justus D; Perez-Albuerne E; Dioguardi J; Jacobsohn D; Abraham A
    Pediatr Blood Cancer; 2015 Jul; 62(7):1285-7. PubMed ID: 25663074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has stem cell transplantation come of age in the treatment of sickle cell disease?
    Shenoy S
    Bone Marrow Transplant; 2007 Nov; 40(9):813-21. PubMed ID: 17704797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Walters MC; De Castro LM; Sullivan KM; Krishnamurti L; Kamani N; Bredeson C; Neuberg D; Hassell KL; Farnia S; Campbell A; Petersdorf E
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):207-211. PubMed ID: 26500093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents.
    Jae GA; Lewkowitz AK; Yang JC; Shen L; Rahman A; Del Toro G
    Ethn Health; 2011; 16(4-5):431-45. PubMed ID: 21797728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell anemia and hematopoietic cell transplantation: When is a pound of cure worth more than an ounce of prevention?
    Walters MC
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():33-8. PubMed ID: 15125704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should young children with sickle cell disease and an available human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation?
    Krishnamurti L
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):53-57. PubMed ID: 32202246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.
    Krishnamurti L; Abel S; Maiers M; Flesch S
    Bone Marrow Transplant; 2003 Apr; 31(7):547-50. PubMed ID: 12692619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell transplantation in children and adults with sickle cell disease: an update.
    Khoury R; Abboud MR
    Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.